Day: July 17, 2020

Genix Pharmaceuticals Corporation Announces Closing of Initial Tranche of Over Subscribed Non-Brokered Private Placement

Staff July 17, 2020

Vancouver, British Columbia--(Newsfile Corp. - July 17, 2020) - Genix Pharmaceuticals Corporation (TSXV: GENX) (the "Company"), is pleased to announce...

DECN Says its Newest GenViro! COVID-19 Swift Kit Saliva Testing Option Can Play an Extensive Role in the Re-Opening of Schools as Company Awaits FDA Authorization

Staff July 17, 2020

"Designed to be swift, safe, non-invasive, and accurate, GenViro! Saliva Based Swift Kit planned to help send students of all...

Voycare Begins Formal Application Process with FINRA for Name, Ticker Symbol and CUSIP Changes

Staff July 17, 2020

COVINA, CA / ACCESSWIRE / July 17, 2020 / North America Frac Sand, Inc. dba Voycare (OTC PINK:NAFS) ("NAFS", "Voycare"...

Rising Biosciences, Inc. Propels Q2 Revenues to Nearly $350,000 Due to Exceptional Growth of Oxi Thyme Division

Staff July 17, 2020

SANDUSKY, OH / ACCESSWIRE / July 17, 2020 / Rising Biosciences, Inc. (OTC PINK:RBII) CEO Arthur Hall announced significant revenue growth...

Pascal Biosciences Announces Feature Article

Staff July 17, 2020

SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / July 17, 2020 / Pascal Biosciences Inc. (TSXV:PAS)(OTC PINK:BIMUF) ("Pascal" or the...

Day: July 17, 2020

Genix Pharmaceuticals Corporation Announces Closing of Initial Tranche of Over Subscribed Non-Brokered Private Placement

DECN Says its Newest GenViro! COVID-19 Swift Kit Saliva Testing Option Can Play an Extensive Role in the Re-Opening of Schools as Company Awaits FDA Authorization

Voycare Begins Formal Application Process with FINRA for Name, Ticker Symbol and CUSIP Changes

Rising Biosciences, Inc. Propels Q2 Revenues to Nearly $350,000 Due to Exceptional Growth of Oxi Thyme Division

Pascal Biosciences Announces Feature Article

Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering

MENU – ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users

AMEEREX Signs MOU to Acquire 45.6 million-Ounce Silver-Gold Project in Nevada, Expanding Its North American Precious-Metals Portfolio

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition

You may have missed